Literature DB >> 11318536

Peptic ulcer occurrence in follow-up of chronic gastritis in patients with treated and not eradicated CagA-positive Helicobacter pylori infection.

R Carratù1, D Iuliano, M R Iovene, F Ferraraccio, P Esposito, M I Russo, F Montella, G Abbate, M A Tufano.   

Abstract

The aim of the present prospective investigation was to study 49 dyspeptic Helicobacter pylori (HP)-positive (HP+) or -negative (HP), CagA+ and CagA- patients with a normal pattern or pure chronic gastritis at initial histology as well as normal features or hyperemic gastropathy at initial endoscopy in a two-year follow up. All the HP+ patients were treated with omeprazole 20 mg twice a day plus amoxicillin 1 g twice a day for two weeks. No substantial change was seen in gastritis in CagA+ patients in whom the infection was not eradicated, and, in contrast, a progressive improvement in 13/14 successfully treated patients was found. At endoscopy, a progressive change to a normal picture was seen in 8 and no change in 6 of 14 patients whose HP infection was eradicated, in contrast a worsening in the 9 HP+ patients who were still infected was observed. In particular, peptic lesions arose in 6 of 21 CagA+ patients in whom the infection was not eradicated. In conclusions, the lack of change in chronic gastritis at histology and the progressive worsening of endoscopic hyperemic gastropathy (with peptic lesions arising in 28,6%) when HP+ CagA+ infection is not eradicated, unlike the progressive improvement of the anatomoclinical condition in the patients whose infection was eradicated, draws attention to the relevance of eradicating HP in CagA+ patients even when no peptic lesion is found at initial endoscopy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11318536     DOI: 10.1023/a:1005607501191

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  34 in total

1.  Prevention of ulcer recurrence after eradication of Helicobacter pylori: a prospective long-term follow-up study.

Authors:  R W Van der Hulst; E A Rauws; B Köycü; J J Keller; M J Bruno; J G Tijssen; G N Tytgat
Journal:  Gastroenterology       Date:  1997-10       Impact factor: 22.682

Review 2.  Helicobacters are indigenous to the human stomach: duodenal ulceration is due to changes in gastric microecology in the modern era.

Authors:  M J Blaser
Journal:  Gut       Date:  1998-11       Impact factor: 23.059

Review 3.  The incidence of Helicobacter pylori infection.

Authors:  J Parsonnet
Journal:  Aliment Pharmacol Ther       Date:  1995       Impact factor: 8.171

Review 4.  Identifiable Helicobacter pylori strains or factors important in the development of duodenal ulcer disease.

Authors:  N Figura
Journal:  Helicobacter       Date:  1997-07       Impact factor: 5.753

5.  Histological classification of gastritis and Helicobacter pylori infection: an agreement at last? The International Workshop on the Histopathology of Gastritis.

Authors:  M F Dixon; R M Genta; J H Yardley; P Correa
Journal:  Helicobacter       Date:  1997-07       Impact factor: 5.753

6.  Immunoglobulin G antibodies to Helicobacter pylori in patients with dyspeptic symptoms investigated by the western immunoblot technique.

Authors:  L P Andersen; F Espersen
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

7.  Helicobacter pylori and atrophic gastritis: importance of the cagA status.

Authors:  E J Kuipers; G I Pérez-Pérez; S G Meuwissen; M J Blaser
Journal:  J Natl Cancer Inst       Date:  1995-12-06       Impact factor: 13.506

8.  When is Helicobacter pylori infection acquired?

Authors:  D J Cullen; B J Collins; K J Christiansen; J Epis; J R Warren; I Surveyor; K J Cullen
Journal:  Gut       Date:  1993-12       Impact factor: 23.059

9.  Helicobacter pylori exotoxins and gastroduodenal diseases associated with cytotoxic strain infection.

Authors:  N Figura
Journal:  Aliment Pharmacol Ther       Date:  1996-04       Impact factor: 8.171

10.  Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach.

Authors:  M J Blaser; G I Perez-Perez; H Kleanthous; T L Cover; R M Peek; P H Chyou; G N Stemmermann; A Nomura
Journal:  Cancer Res       Date:  1995-05-15       Impact factor: 12.701

View more
  1 in total

Review 1.  The dynamics of gastritis.

Authors:  E J Kuipers; T A Grool
Journal:  Curr Gastroenterol Rep       Date:  2001-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.